GPT and fibrosis: While for those who had no advanced fibrosis or cirrhosis, serum ALT should be monitored every 3 months, and if elevated ALT >2 × baseline detected at monitoring, HBsAg and HBV DNA should be performed and high-resistant barrier NUCs initiated if either test positive.